Prudentia Sciences - About the company
Prudentia Sciences is a series A company based in Cambridge (United States), founded in 2023. It operates as a Provider of AI-powered drug asset diligence and valuation. Prudentia Sciences has raised $27M in funding from Google Ventures and McKesson Ventures. The company has 91 active competitors, including 13 funded and 1 that has exited. Its top competitors include companies like Lila Sciences, Fauna Bio and BeaconCure.
Company Details
Provider of AI-powered drug asset diligence and valuation. This platform offers real-time data-driven simulation and scenario planning to optimize asset valuation for deal terms, enabling faster decision-making and increased deal throughput. It rapidly synthesizes data room information into an asset assessment framework and product profile, facilitating comparisons with public and proprietary data and benchmarks. The platform also provides AI-guided product profiles and asset valuations to guide portfolio strategy and decision-making, and includes multi-disciplinary expert-in-the-loop deal analysis and modeling with real-time analytics. The system features traceable AI, evidence-based insights, and robust security measures.
- Website
- www.prudentiasciences.com
- Email ID
- *****@prudentiasciences.com
- Registered Address
- 518 ROUTE DE CHAMPIALET 07370 SARRAS
Key Metrics
Founded Year
2023
Location
Cambridge, United States
Stage
Series A
Total Funding
$27M in 2 rounds
Latest Funding Round
Investors
Ranked
4th among 91 active competitors
Employee Count
22 as on Jul 31, 2026
Legal entities associated with Prudentia Sciences
Prudentia Sciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PRUDENTIA CIN: 985206218 , France, Active | Mar 04, 2024 | - | - | - |
Sign up to download Prudentia Sciences' company profile
Prudentia Sciences's funding and investors
Prudentia Sciences has raised a total funding of $27M over 2 rounds. Its first funding round was on Jan 09, 2025. Its latest funding round was a Series A round on Jan 07, 2026 for $*****. 5 investors participated in its latest round. Prudentia Sciences has 5 institutional investors.
Here is the list of recent funding rounds of Prudentia Sciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 07, 2026 | 3060184 | Series A | 4518969 | 3271543 | 7361646 | 3013817 |
Jan 09, 2025 | 5933780 | Series A | 8055894 | 7135737 |
Access funding benchmarks and valuations. Sign up today!View details of Prudentia Sciences's funding rounds and investors
Prudentia Sciences' founders and board of directors
Founder? Claim ProfilePrudentia Sciences' employee count trend
Prudentia Sciences has 22 employees as of Jul 26. Here is Prudentia Sciences's employee count trend over the years:
Uncover Prudentia Sciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Prudentia Sciences's Competitors and alternates
Top competitors of Prudentia Sciences include Lila Sciences, Fauna Bio and BeaconCure. Here is the list of Top 10 competitors of Prudentia Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lila Sciences 2023, Cambridge (United States), Series A | Developer of AI-powered autonomous scientific research platforms | $550M | 65/100 | |
2nd |  Fauna Bio 2018, Berkeley (United States), Seed | Healthcare association involved in animal genomics | $13.1M | 53/100 | |
3rd | BeaconCure 2016, Tel Aviv (Israel), Series C | Developer of an AI-enabled statistical analysis platform for biometrics teams | $40.9M | 49/100 | |
4th | Prudentia Sciences 2023, Cambridge (United States), Series A | Provider of AI-powered drug asset diligence and valuation | $27M | 48/100 | |
5th |  Iomed Health 2016, Spain, Series A | Provider of an AI-based Software for collecting EMR for clinical research | $13.1M | 42/100 | |
6th |  BGM Group Ltd China, Public | Provider of AI-driven solutions for biopharma and insurance | - | - | 39/100 |
7th |  Gesund AI 2021, Cambridge (United States), Seed | Provider of clinical-grade AI solutions for regulatory compliance | $2M | 38/100 | |
8th |  Voiant 2023, United States, Unfunded | Provider of AI-driven clinical trial imaging solutions | - | - | 37/100 |
9th | MiBA 2022, Tampa (United States), Unfunded | Healthcare AI technology company providing data for cancer research, clinical trial matching, pharma utilization, and new drug development | - | - | 36/100 |
10th | Verisian 2023, London (United Kingdom), Seed | Developer of clinical trial analysis solutions using traceability and AI | $1.25M | 35/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Prudentia Sciences's competitors? Click here to see the top ones
Prudentia Sciences's Investments and acquisitions
Prudentia Sciences has made no investments or acquisitions yet.
Reports related to Prudentia Sciences
Here is the latest report on Prudentia Sciences's sector:
News related to Prudentia Sciences
Media has covered Prudentia Sciences for 1 event in last 1 year.
•
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences DealmakingBusiness Wire•Jan 07, 2026•McKesson Ventures, Prudentia Sciences, Virtue, Iaso Ventures and 3 others
•
Prudentia Sciences Launches with $7M in Funding to Transform the Life Sciences Marketplace for DealmakingBusiness Wire•Jan 09, 2025•Prudentia Sciences, Google Ventures, Iaso Ventures, Virtue
•
Prudentia Sciences Raises $7M in FundingFinSMEs•Jan 09, 2025•Prudentia Sciences, Google Ventures, Iaso Ventures, Virtue
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Prudentia Sciences
Explore our recently published companies
- Alexandra Cohen - Founder - United States based, 2025 founded, Stealth company
- Alexander Wyn Stewart - Co-founder and CEO - France based, 2025 founded, Stealth company
- Aurelio Mofuga - Stealth Founder - Tanzania based, 2025 founded, Stealth company
- Abhinav Nikam - Co-Founder - India based, 2025 founded, Stealth company
- Niels Abdellatif - Co-Founder - Netherlands based, 2025 founded, Stealth company
- Chloe Adams - Scientist - Seattle based, 2025 founded, Stealth company
